Webinar | Avoiding azathioprine toxicity due to TPMT mutations in renal transplant recipients

This webinar presented a case study and explored recommendations for avoiding azathioprine toxicity due to TPMT mutations in renal transplant patients.

Presented by Professor David Power, Director of Nephrology at Austin Health, the webinar considered the findings of a recent coronial investigation where a renal transplant patient died with profound leucopenia following a change in medication from mycophenolic acid to azathioprine.

Download the slides